日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multiomic Characterization of Pre- and Post-Neoadjuvant Chemotherapy-Treated Ovarian Cancer Reveals Mediators of Tumorigenesis and Chemotherapy Response

新辅助化疗前后卵巢癌的多组学特征分析揭示了肿瘤发生和化疗反应的介质

Valentine, Mark C; Mullen, Mary M; Kotnik, Emilee N; Powell, Matthew A; Thaker, Premal H; McCourt, Carolyn K; Kuroki, Lindsay M; Hagemann, Andrea R; Arend, Rebecca C; Holehouse, Alex S; Mitra, Robi; Mutch, David G; Fuh, Katherine C

Enhancing Progestin Therapy with a Glucagon-Like Peptide 1 Agonist for the Conservative Management of Endometrial Cancer.

使用胰高血糖素样肽-1激动剂增强孕激素疗法治疗子宫内膜癌的保守治疗

Hagemann Andrea R, Hagemann Ian S, Mutch David G, Devor Eric J, Malmrose Paige K, Zhang Yuping, Morrison Abigail M, Thiel Kristina W, Leslie Kimberly K

Integration of a lifestyle modification intervention for women with overweight and obesity in a gynecologic oncology practice

将生活方式干预措施融入妇科肿瘤诊疗实践中,以改善超重和肥胖女性的健康状况。

Morris, David H; Kosmacki, Alison; Tolby, Leah; Marx, Christine; Vanderlan, Jessica; Mutch, David G; Colditz, Graham; Hagemann, Andrea R

Prospective assessment of prognostic significance of malignant peritoneal cytology in endometrial cancer: An NRG Oncology / Gynecologic Oncology Group study on GOG-210 protocol

前瞻性评估腹膜恶性细胞学在子宫内膜癌预后中的意义:一项基于 GOG-210 方案的 NRG 肿瘤/妇科肿瘤协作组研究

Matsuo, Koji; Enserro, Danielle M; Wright, Jason D; Roman, Lynda D; Powell, Matthew A; Miller, David S; Nagel, Christa I; Thaker, Premal H; Mannel, Robert S; Stuckey, Ashley R; Guntupalli, Saketh R; Sukumvanich, Paniti; Geller, Melissa A; Vargas, Roberto; Konecny, Gottfried E; Warshal, David P; Tewari, Krishnansu S; Spirtos, Nick M; Pothuri, Bhavana; Creasman, William T; Mutch, David G

Cancer of the corpus uteri: A 2025 update

子宫体癌:2025 年最新进展

Koskas, Martin; Crosbie, Emma J; Fokdal, Lars; McCluggage, W Glenn; Mileshkin, Linda; Mutch, David G; Amant, Frédéric

Targeting RAD52 overcomes PARP inhibitor resistance in preclinical Brca2-deficient ovarian cancer model.

在临床前 Brca2 缺陷型卵巢癌模型中,靶向 RAD52 可克服 PARP 抑制剂耐药性。

Ota Yukihide, Gupta Vijayalaxmi, Fashemi Bisiayo E, Akande Moreniola, Babu Preedia, Thuthika Prasanth, Elizagaray Maia L, Sun Lulu, Sanders Brooke, Kuroki Lindsay M, McCourt Carolyn K, Hagemann Andrea R, Hagemann Ian S, Thaker Premal H, Mutch David G, Powell Matthew A, Hyrc Krzysztof, Verma Priyanka, Krais John, Bitler Benjamin G, Mullen Mary, Khabele Dineo

Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study

鲁索替尼联合一线新辅助治疗晚期卵巢癌的I期和随机II期研究:NRG肿瘤协作组研究

Landen, Charles N; Buckanovich, Ronald J; Sill, Michael W; Mannel, Robert S; Walker, Joan L; DiSilvestro, Paul A; Mathews, Cara A; Mutch, David G; Hernandez, Marcia L; Martin, Lainie P; Bishop, Erin; Gill, Sarah E; Gordinier, Mary E; Burger, Robert A; Aghajanian, Carol; Liu, Joyce F; Moore, Kathleen N; Bookman, Michael A

Accuracy of surveillance serum squamous cell carcinoma antigen for cervical cancer recurrence after definitive chemoradiation

血清鳞状细胞癌抗原监测在宫颈癌根治性放化疗后复发预测中的准确性

Shi, Victoria; Grover, Surbhi; Huang, Yi; Thaker, Premal H; Kuroki, Lindsay M; Powell, Matthew A; Mutch, David G; Contreras, Jessika A; Schwarz, Julie K; Grigsby, Perry W; Markovina, Stephanie

A toolkit for a modern gynecologic oncology tissue bank

现代妇科肿瘤组织库工具包

Graham, Olivia; Rodriguez, Jeimmy; Abbott, Rachel; Lomonosova, Elena; Fashemi, Bisiayo; Drexler, Rebecca; Grither, Whitney; Rodriguez, Kevin; Compadre, Amanda; Loeb, Megan; Sanders, Brooke; Kuroki, Lindsay; Hagemann, Andrea R; McCourt, Carolyn; Thaker, Premal H; Fuh, Katherine; Powell, Matthew A; Hagemann, Ian S; Mutch, David G; Khabele, Dineo; Mullen, Mary M

Prophylactic antibiotics for excision of premalignant vulvar lesions: A pilot randomized controlled trial

预防性使用抗生素治疗外阴癌前病变切除术:一项初步随机对照试验

Mullen, Mary M; Grither, Whitney R; Millimet, Hannah; Mutch, David G; Hagemann, Andrea R; McCourt, Carolyn K; Powell, Matthew A; H Thaker, Premal; Khabele, Dineo; Kuroki, Lindsay M